Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China.
CONCLUSIONS Our individualized preconditioning protocol evolved as our experience grew, and the short-term clinical outcomes of ABOi KTx did not differ from those of matched ABOc patients. ABOi KTx may be a major step forward in expanding the kidney living-donor pool in China.
PMID: 32029699 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Wang XD, Liu JP, Fan Y, Song TR, Shi YY, Li YM, Lv YH, Li XH, Huang ZL, Lin T Tags: Ann Transplant Source Type: research
More News: China Health | Kidney Transplant | Kidney Transplantation | Rituxan | Thrombocytopenia | Transplant Surgery | Transplants | Urology & Nephrology